Tuesday, May 16, 2023

GPT4 Critiques Medical Letter against UHC Prior Auth for Colonoscopies.

As discussed in several current articles, physician associations are concerned about new prior auth rules for colonoscopies and write the insurer a letter.

http://www.discoveriesinhealthpolicy.com/2023/05/united-healthcare-stat-says-colonoscopy.html

https://www.fiercehealthcare.com/payers/unitedhealthcares-prior-authorization-policy-colonoscopies-draws-more-fire?itm_source=parsely-api

Letter PDF:  https://www.statnews.com/wp-content/uploads/2023/05/Multi-organizational-letter-to-UHC-re-GI-endoscopy-prior-auth-program_05082023.pdf


I asked GPT4 to summarize the letter, critique the letter, and offer improvements.

Summary of the Letter

The letter from the medical associations criticizes United Healthcare's new prior authorization program for gastrointestinal (GI) endoscopy, including colonoscopies. They argue that it will harm patients, limit access to care for vulnerable populations, delay colorectal cancer diagnosis in younger populations, and unnecessarily increase the burden on physicians and their practice.

The associations highlight several areas of concern:

  1. Impact on patients: The policy could deter patients from undergoing medically recommended colonoscopies after polyps or cancers are removed or for diagnostic testing. The requirement for prior authorization could lead to treatment abandonment, with 80% of physicians reporting such outcomes due to the process.

  2. Delay in care for high-risk individuals: The policy could cause delays in care for high-risk individuals, as it requires prior authorization even for patients deemed high-risk for colorectal cancer by a physician.

  3. Unintended limitation of screening colonoscopies: Despite the claim that screening colonoscopies are exempt, there is confusion due to lack of explicit coding instructions, potentially resulting in the need for prior authorization.

  4. Increased burden on physicians: The policy is likely to increase the administrative burden on physicians, who already complete an average of 45 prior authorizations per week per physician.

  5. Lack of overutilization evidence: The associations challenge the need for the policy by questioning the evidence of overutilization, as UHC has not provided data to support this.

  6. Focus on cost control over patient care: The policy is criticized for seemingly prioritizing cost control over improving patient care.

Critique of the Letter

While the letter raises several valid concerns, it could be improved in several ways:

  1. Lack of data and evidence: The letter could be strengthened by including more data and empirical evidence to support its claims. For instance, data showing the number of patients who could be affected by this policy or specific examples where similar policies have led to negative outcomes could be useful.

  2. Lack of proposed solutions: The letter is largely focused on criticizing the policy but doesn't offer concrete alternatives or solutions. Offering a well thought out alternative could make the letter more persuasive.

  3. Overgeneralization of the problem: The letter assumes that all endoscopic procedures will be affected equally by this policy. However, it does not take into account the possibility that UHC might be more flexible for certain procedures or patient types.

  4. Arguments based on anecdotes: Some of the arguments, such as the increase in physicians' burdens, are presented as anecdotal evidence. Including more comprehensive data or peer-reviewed studies could strengthen these claims.

  5. Assumptions about motives: The letter assumes that UHC's primary motive is cost control. While this might be true, it could be more constructive to engage with the possibility that UHC has valid reasons for implementing this policy, such as preventing unnecessary procedures or improving overall patient care.

How to Improve the Letter

  1. Include more data and evidence: The letter could include more specific data and research to back up its claims.

  2. Propose alternatives: The letter could suggest alternative measures that UHC could take to control costs or prevent overutilization, without impacting patient care negatively.

  3. Consider UHC's perspective: The letter could engage more directly with UHC's stated reasons for implementing the policy, offering a more balanced critique.

  4. Specify the impact on different procedures: The letter could provide more detail on how the policy might affect different types of procedures and patients, rather than treating all endoscopic procedures as a monolith.

  5. Offer to collaborate: The letter could propose a collaboration between the medical associations and UHC to find a solution that balances the needs of both parties.

###
GPT4 also rewrote the letter, shortening it considerably:

Dear United Healthcare Leadership,

We write on behalf of various medical associations to express our concerns regarding the newly instituted policy of requiring prior authorization for gastrointestinal (GI) endoscopy procedures, including colonoscopies. While we understand the necessity to ensure appropriate utilization of healthcare resources, we are deeply concerned about the unintended consequences of this policy, particularly regarding its potential impact on patient care and physician workload.

Patient Care and Delays in Diagnosis

The National Cancer Institute highlights that colorectal cancer is a prominent cause of cancer death among Americans under 50, with the incidence rate still rising. We are worried that the new prior authorization policy, albeit excluding screening colonoscopies, might unintentionally discourage patients from undergoing vital subsequent colonoscopies following the removal of polyps or cancers, or when diagnostic testing is warranted due to alarming symptoms.

The Center for Consumer Information and Insurance Oversight (CCIIO) identifies 'high-risk' individuals through clinical expertise. If a patient is deemed high-risk for colorectal cancer by a medical provider, they are entitled to receive services in accordance with the recommendations of the U.S. Preventive Services Task Force, without cost-sharing. However, under the new policy, these high-risk patients would need to wait for approval via the prior authorization process before receiving essential care.

Coding and Scope of Prior Authorization

We acknowledge that the policy intends to exclude screening colonoscopies. However, the absence of clear coding instructions could lead to confusion and may inadvertently necessitate prior authorization for these procedures. We recommend that UHC provide explicit coding instructions and allocate adequate time for physician education to prevent this ambiguity.

Physician Workload and Overutilization Concerns

The policy, as it stands, is likely to increase the administrative burden on physicians. We would like to highlight a study by the American Medical Association which suggests that the average practice completes 45 prior authorizations per week per physician, equating to 14 hours of paperwork weekly. The introduction of further administrative requirements could detract from patient care.

Our understanding is that the policy was developed to curb overutilization. However, we have not seen evidence from UHC to substantiate the overutilization of any GI endoscopic or capsule endoscopy procedure. We recommend a collaborative review of procedure utilization data to identify specific procedures of concern and develop educational initiatives for appropriate utilization.

Balancing Cost Control and Patient Care

We recognize the importance of managing healthcare costs, but it is crucial to balance this with the imperative of delivering quality patient care. We believe that broad limitations on care might not be the optimal solution. We suggest a more nuanced approach, focusing on specific procedures where overutilization is demonstrable and cost savings can be achieved without compromising patient care.

In summary, while we appreciate UHC's efforts to optimize resources and ensure quality care, we are concerned about the possible unintended consequences of the current prior authorization policy. We suggest a collaborative effort between UHC and the medical associations to review the policy and develop a solution that balances cost control, appropriate procedure utilization, and, most importantly, quality patient care.

We look forward to engaging in constructive dialogue on this issue.

Yours sincerely,

[Your Name] [Your Position] [Your Contact Information]

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.